Skip to main content
. Author manuscript; available in PMC: 2015 May 11.
Published in final edited form as: Chem Commun (Camb). 2014 May 11;50(36):4659–4673. doi: 10.1039/c4cc00660g

Fig. 6.

Fig. 6

Several classes of therapeutics, including (a) immune stimulants, (b) bulky groups, (c) photosensitizers, (d) nanoparticles, and (e) lipophilic molecules, have the potential to catalyse cellular damage or render bacteria innocuous if they are covalently delivered to chemical reporter-labelled glycans on bacterial cells.